用于膀癌治疗的抗生物受体网状微运动器
Jun Sun1, Ran Chu2, Xiaoqian Wu1
1State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210023, China.
Journal of the American Chemical Society
|May 16, 2025
概括
在癌症治疗中使用酶驱动的纳米发动机的寿命更长. 新的富含的金属有机框架可以防止失活, 提高膀癌症的治疗效果.
科学领域:
- 生物医学工程
- 材料科学
- 纳米技术
背景情况:
- 由酶驱动的微/纳米电机 (MNM) 由于在瘤微环境中快速失活,因此在生物医学上应用有限.
- 生物化,即发动机被生物成分污染, 显著缩短了它们的使用寿命.
研究的目的:
- 为膀癌治疗设计具有增强运动性的抗生物受体化尿酶驱动的MOF电机 (Ur-MOFtors).
- 调查持续运动和抗生物化特性背后的机制.
主要方法:
- 使用富含键的金属有机框架 (MOF) 来制造酶驱动的电机.
- 在缩尿素溶液中研究的运动寿命.
- 使用现场红外光谱和密度函数理论来阐明持久运动的机制.
- 通过离子自我扩散和化学反应对尿素进行自我推进.
- 通过静脉注射治疗膀癌的疗效.
主要成果:
- 在缩尿素中,Ur-MOFtors的运动寿命超过了90分钟,比尿素酶吸附的MOF提高了18倍.
- 实现了优异的抗生物化,保持了与原生尿素酶相比较的酶活性.
- 确定MOF骨架和催化产品之间的结为持续运动的关键.
- 证实了离子自我扩散作为对尿素的积极化学反应的推进机制.
结论:
- 富含键的MOF为创造具有延长寿命的抗生物受酶电机提供了可行的策略.
- Ur-MOFtors为先进的治疗机器人提供了一个有前途的平台,特别是通过静脉注射治疗膀癌症.
- 这种方法克服了生理环境中酶电机的短寿命和失活的局限性.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Therapies
8.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K


